Vaccinex, Inc. (VCNX): Operating Cash Flow

Annual figures by period end, from SEC filings.

Not updated since 2024-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2023-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

-$16.19M

Year ended 2024-12-31

2017-12-31 Operating Cash Flow (USD) 2024-12-31

Period ended	Operating Cash Flow	Change YoY	Source filing
2024-12-31	-$16.19M	n/m	2025-04-15, From 2024-01-01
2023-12-31	-$21.38M	n/c	2025-04-15, From 2023-01-01
2022-12-31	-$19.07M	n/m	2024-04-25, From 2022-01-01
2021-12-31	-$25.30M	n/m	2023-03-31, From 2021-01-01
2020-12-31	-$28.65M	n/m	2022-03-31, From 2020-01-01
2019-12-31	-$30.71M	n/m	2021-03-31, From 2019-01-01
2018-12-31	-$25.28M	n/m	2020-03-09, From 2018-01-01
2017-12-31	-$21.39M	n/a	2019-03-13, From 2017-01-01